Article
New aspects of chronic beryllium disease.
Current opinion in allergy and clinical immunology - 1 Apr 2026
Morgan Amanda, MacMurdo Maeve G
Abstract excerpt
PURPOSE OF REVIEW: Chronic beryllium disease (CBD) is a granulomatous lung disorder resulting from a cell-mediated immune response to beryllium exposure. Despite exposure regulations, new cases continue to emerge across both traditional and nontraditional occupational settings. In this review, we underscore ongoing diagnostic and preventive challenges, and strategies for screening and treatment of beryllium...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
